Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease

Overview

Journal Pharmacoeconomics

Specialty Pharmacology

Date 2015 Aug 3

PMID 26233836

Citations 35

Authors

Zobair M Younossi

Linda Henry

Affiliations

Soon will be listed here.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a very common chronic liver disease worldwide, is on the rise following the trend of increasing prevalence of obesity, is the second most common indication for liver transplantation, and is an important cause for hepatocellular carcinoma. Despite the increasing recognition of NAFLD as an important chronic liver disease, little has been published on the economic and health-related quality of life (HR-QOL) impact of NAFLD. We reviewed the current literature related to the economics and HR-QOL of NAFLD and found that increased costs and decreased HR-QOL were associated with NAFLD.

Citing Articles

Remnant cholesterol and its variability independent of low density lipoprotein cholesterol predict metabolic dysfunction associated steatotic liver disease.

Sun Y, Miao X, Hu M, Xie X, Liu S, Song Z Sci Rep. 2025; 15(1):4455.

PMID: 39910118 PMC: 11799198. DOI: 10.1038/s41598-025-88000-9.

Parallel randomised trial testing community fibrosis assessment for suspected non-alcoholic fatty liver disease: outcomes from LOCATE-NAFLD.

Tulleners R, Barnett A, OBeirne J, Powell E, Hickman I, Valery P BMJ Open Gastroenterol. 2025; 11(1.

PMID: 39797660 PMC: 11664381. DOI: 10.1136/bmjgast-2024-001418.

Projected Healthcare System Cost Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease in Canada.

Memedovich K, Shaheen A, Swain M, Clement F Gastro Hep Adv. 2024; 3(7):965-972.

PMID: 39286617 PMC: 11403419. DOI: 10.1016/j.gastha.2024.05.010.

Evaluation of risk factors for non-alcoholic fatty liver disease in India: A systematic review and meta-analysis.

Kannan S, Nelliyanil M, Mendagudli R, Rajeshwari S, Kona C, Kundapur R J Educ Health Promot. 2024; 12:435.

PMID: 38464628 PMC: 10920698. DOI: 10.4103/jehp.jehp_208_23.

Advances in Unhealthy Nutrition and Circadian Dysregulation in Pathophysiology of NAFLD.

Guo X, Zheng J, Zhang S, Jiang X, Chen T, Yu J Front Clin Diabetes Healthc. 2023; 2:691828.

PMID: 36994336 PMC: 10012147. DOI: 10.3389/fcdhc.2021.691828.

References

Picot J, Jones J, Colquitt J, Gospodarevskaya E, Loveman E, Baxter L . The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009; 13(41):1-190, 215-357, iii-iv. DOI: 10.3310/hta13410. View

Barker K, Palekar N, Bowers S, Goldberg J, Pulcini J, Harrison S . Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery. Am J Gastroenterol. 2006; 101(2):368-73. DOI: 10.1111/j.1572-0241.2006.00419.x. View

Wang Z, Xu M, Peng J, Jiang L, Hu Z, Wang H . Prevalence and associated metabolic factors of fatty liver disease in the elderly. Exp Gerontol. 2013; 48(8):705-9. DOI: 10.1016/j.exger.2013.05.059. View

Newton J, Pairman J, Wilton K, Jones D, Day C . Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease. Clin Auton Res. 2009; 19(6):319-26. DOI: 10.1007/s10286-009-0031-4. View

Surdea-Blaga T, Dumitrascu D . Depression and anxiety in nonalcoholic steatohepatitis: is there any association?. Rom J Intern Med. 2012; 49(4):273-80. View

Bertolotti M, Lonardo A, Mussi C, Baldelli E, Pellegrini E, Ballestri S . Nonalcoholic fatty liver disease and aging: epidemiology to management. World J Gastroenterol. 2014; 20(39):14185-204. PMC: 4202348. DOI: 10.3748/wjg.v20.i39.14185. View

Vanni E, Bugianesi E, Kotronen A, De Minicis S, Yki-Jarvinen H, Svegliati-Baroni G . From the metabolic syndrome to NAFLD or vice versa?. Dig Liver Dis. 2010; 42(5):320-30. DOI: 10.1016/j.dld.2010.01.016. View

Wong R, Aguilar M, Cheung R, Perumpail R, Harrison S, Younossi Z . Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2014; 148(3):547-55. DOI: 10.1053/j.gastro.2014.11.039. View

Barshop N, Sirlin C, Schwimmer J, Lavine J . Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2008; 28(1):13-24. DOI: 10.1111/j.1365-2036.2008.03703.x. View

10.

Hickman I, Jonsson J, Prins J, Ash S, Purdie D, Clouston A . Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut. 2004; 53(3):413-9. PMC: 1773957. DOI: 10.1136/gut.2003.027581. View

11.

Kalaitzakis E . Fatigue in non-alcoholic fatty liver disease: is there a role for hypothyroidism. Gut. 2008; 58(1):149-50. View

12.

Stepanova M, Younossi Z . Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clin Gastroenterol Hepatol. 2012; 10(6):646-50. DOI: 10.1016/j.cgh.2011.12.039. View

13.

Martini E, Garrett N, Lindquist T, Isham G . The boomers are coming: a total cost of care model of the impact of population aging on health care costs in the United States by Major Practice Category. Health Serv Res. 2007; 42(1 Pt 1):201-18. PMC: 1955745. DOI: 10.1111/j.1475-6773.2006.00607.x. View

14.

Dan A, Kallman J, Wheeler A, Younoszai Z, Collantes R, Bondini S . Health-related quality of life in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2007; 26(6):815-20. DOI: 10.1111/j.1365-2036.2007.03426.x. View

15.

Brunt E, Kleiner D, Wilson L, Belt P, Neuschwander-Tetri B . Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology. 2011; 53(3):810-20. PMC: 3079483. DOI: 10.1002/hep.24127. View

16.

Davis G, Roberts W . The healthcare burden imposed by liver disease in aging Baby Boomers. Curr Gastroenterol Rep. 2010; 12(1):1-6. DOI: 10.1007/s11894-009-0087-2. View

17.

Younossi Z, Zheng L, Stepanova M, Henry L, Venkatesan C, Mishra A . Trends in outpatient resource utilizations and outcomes for Medicare beneficiaries with nonalcoholic fatty liver disease. J Clin Gastroenterol. 2014; 49(3):222-7. DOI: 10.1097/MCG.0000000000000071. View

18.

Baumeister S, Volzke H, Marschall P, John U, Schmidt C, Flessa S . Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation. Gastroenterology. 2007; 134(1):85-94. DOI: 10.1053/j.gastro.2007.10.024. View

19.

Loveman E, Frampton G, Shepherd J, Picot J, Cooper K, Bryant J . The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review. Health Technol Assess. 2011; 15(2):1-182. PMC: 4781196. DOI: 10.3310/hta15020. View

20.

Younossi Z, Stepanova M, Negro F, Hallaji S, Younossi Y, Lam B . Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore). 2012; 91(6):319-327. DOI: 10.1097/MD.0b013e3182779d49. View